These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35180114)

  • 1. Neuropsychiatric Inventory-Questionnaire Assessed Nighttime Behaviors in Cognitively Asymptomatic Patients with Pathologically Confirmed Alzheimer's Disease Predict More Rapid Cognitive Deterioration.
    Atayde AL; Fischer CE; Schweizer TA; Munoz DG
    J Alzheimers Dis; 2022; 86(3):1137-1147. PubMed ID: 35180114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychiatric Inventory-Assessed Nighttime Behavior Accompanies, but Does Not Precede, Progressive Cognitive Decline Independent of Alzheimer's Disease Histopathology.
    Atayde AL; Fischer CE; Schweizer TA; Munoz DG
    J Alzheimers Dis; 2020; 74(3):839-850. PubMed ID: 32116249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease.
    Ringman JM; Sachs MC; Zhou Y; Monsell SE; Saver JL; Vinters HV
    JAMA Neurol; 2014 Jul; 71(7):878-83. PubMed ID: 24797962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediation of Reduced Hippocampal Volume by Cerebral Amyloid Angiopathy in Pathologically Confirmed Patients with Alzheimer's Disease.
    Nagaraja N; Wang WE; Duara R; DeKosky ST; Vaillancourt D
    J Alzheimers Dis; 2023; 93(2):495-507. PubMed ID: 37038809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E ɛ4 (APOE ɛ4) Allele is Associated with Long Sleep Duration Among Elderly with Cognitive Impairment.
    Basta M; Zaganas I; Simos P; Koutentaki E; Dimovasili C; Mathioudakis L; Bourbouli M; Panagiotakis S; Kapetanaki S; Vgontzas A
    J Alzheimers Dis; 2021; 79(2):763-771. PubMed ID: 33361595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease.
    Tian J; Shi J; Bailey K; Lendon CL; Pickering-Brown SM; Mann DM
    J Neurol Neurosurg Psychiatry; 2004 May; 75(5):696-9. PubMed ID: 15090562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4.
    Olichney JM; Hansen LA; Hofstetter CR; Lee JH; Katzman R; Thal LJ
    Arch Neurol; 2000 Jun; 57(6):869-74. PubMed ID: 10867785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chain Mediation Analysis of the Effects of Nutrition and Cognition on the Association of Apolipoprotein E ɛ4 with Neuropsychiatric Symptoms in Alzheimer's Disease.
    Jiang J; Hong Y; Li W; Wang A; Jiang S; Jiang T; Wang Y; Wang L; Yang S; Ren Q; Zou X; Xu J
    J Alzheimers Dis; 2023; 96(2):669-681. PubMed ID: 37840496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease.
    Shinohara M; Murray ME; Frank RD; Shinohara M; DeTure M; Yamazaki Y; Tachibana M; Atagi Y; Davis MD; Liu CC; Zhao N; Painter MM; Petersen RC; Fryer JD; Crook JE; Dickson DW; Bu G; Kanekiyo T
    Acta Neuropathol; 2016 Aug; 132(2):225-234. PubMed ID: 27179972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease and other cerebrovascular neuropathologic changes.
    Brenowitz WD; Nelson PT; Besser LM; Heller KB; Kukull WA
    Neurobiol Aging; 2015 Oct; 36(10):2702-8. PubMed ID: 26239176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologically Confirmed Cerebral Amyloid Angiopathy with No Radiological Sign in a Patient with Early Onset Alzheimer's Disease.
    Kim SJ; Seo Y; Kim HJ; Na DL; Seo SW; Kim Y; Suh YL
    Yonsei Med J; 2018 Aug; 59(6):801-805. PubMed ID: 29978619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
    Chalmers K; Wilcock GK; Love S
    Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOE ɛ4/ɛ4 Is Associated with Aberrant Motor Behavior Through Both Lewy Body and Cerebral Amyloid Angiopathy Pathology in High Alzheimer's Disease Pathological Load.
    Garcia-Segura ME; Fischer CE; Schweizer TA; Munoz DG
    J Alzheimers Dis; 2019; 72(4):1077-1087. PubMed ID: 31744003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
    De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
    J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The APOE ɛ4/ɛ4 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer's disease patients.
    Hultman K; Strickland S; Norris EH
    J Cereb Blood Flow Metab; 2013 Aug; 33(8):1251-8. PubMed ID: 23652625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
    Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
    Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer's disease.
    Reddy JS; Allen M; Ho CCG; Oatman SR; İş Ö; Quicksall ZS; Wang X; Jin J; Patel TA; Carnwath TP; Nguyen TT; Malphrus KG; Lincoln SJ; Carrasquillo MM; Crook JE; Kanekiyo T; Murray ME; Bu G; Dickson DW; Ertekin-Taner N
    Acta Neuropathol Commun; 2021 May; 9(1):93. PubMed ID: 34020725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular Dysfunction Is Central to Alzheimer's Disease Pathogenesis in APOE e4 Carriers.
    McCorkindale AN; Mundell HD; Guennewig B; Sutherland GT
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.